From: APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential
Germline variant | Genomic location | Risk allele or amino acid | Cancer | Molecular impact* | Effect on cancer risk* | References |
---|---|---|---|---|---|---|
rs139293 | Exon 2 of APOBEC3H | T | Lung | Activity-decreasing amino acid change (R18L) and lower expression of APOBEC3H and APOBEC3C | Decreased | [107] |
rs1014971 Linked proxies: rs17000526 rs1004748 | Intergenic region ~ 25 kb from APOBEC3A | T | Bladder | Increased APOBEC3B expression and more APOBEC3-induced mutations | Increased | [61] |
N/A | Increased | [63] | ||||
N/A | Increased overall and for high-risk tumors | [103] | ||||
Breast | Increased APOBEC3B expression but no association with APOBEC3-induced mutation burden | Moderately increased | [61] | |||
rs2267401 | APOBEC3B promoter | G | Bile duct | Increased APOBEC3B promoter activity | Increased | [43] |
 |  |  | Liver | Increased APOBEC3B expression with stronger promoter response to IL-6 and more APOBEC3-induced HBV mutations | Increased | [86] |
 |  |  | Gallbladder | Decreased APOBEC3B promoter activity | Decreased | [43] |
rs12157810 | APOBEC3A promoter | C | Bile duct | Increased APOBEC3A promoter activity | Decreased | [43] |
 |  |  | Gallbladder | Increased APOBEC3A promoter activity | Decreased | [43] |
 |  |  | Renal | Higher APOBEC3A expression and increased promoter sensitivity to TNF-α | Decreased | [108] |
 |  |  | Colorectal | No change in promoter responsiveness to TNF-α, but decreased response to IL-6 | N/A | [108] |
APOBEC3H Haplotype I | APOBEC3H | Â | Lung | Gly105 creates unstable APOBEC3H protein with increased nuclear localization | Increased | [65] |
rs34522862 | Exon 2 | Asn | ||||
rs139293 | Exon 2 | Arg | ||||
rs139297 | Exon 3 | Gly | ||||
rs139299 | Exon 3 | Lys | ||||
re139298 | Exon 3 | Lys | ||||
rs139302 | Exon 4 | Glu | ||||
rs139298 | APOBEC3H Exon 3 | Glu | Lung | K121E within APOBEC3H haplotype I destabilizes protein, potentially creating fewer mutations to avoid immune response | Decreased relative to standard haplotype I | [106] |
APOBEC3A/B chimera Proxy: rs12628403 | Coding region of APOBEC3B |  ~ 30 kb deletion | Breast | Enrichment of APOBEC3-induced mutations | Increased | [61] |
 |  |  |  | Increased APOBEC3-induced mutation load | N/A | [62] |
 |  |  |  | Higher abundance of tumor-infiltrating immune cells | Increased | [109] |
 |  |  |  | N/A | Increased for higher histological grade | [64] |
 |  |  |  | Hypermutated phenotype with immune activation | N/A | [105] |
 |  |  | Leukemia | Hypermutated tumor genome | N/A | [62] |
 |  |  | Ovarian | N/A | Decreased | [110] |
 |  |  | Bladder | No association | No association | [61] |
APOBEC3B indel | Exon 5 of APOBEC3B | Deletion | Breast | N/A | Increased | [111] |